SEPTInvestingStart Free

PASG 10-Q: SEC filing

Passage BIO

Filed with the SEC on · accession 0001104659-26-124783

PASG filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +1.6% by the first close after the filing.

Summary of the filing

Passage BIO filed its Q3 2026 10-Q, reporting continued operating losses and a going concern uncertainty, with no major corporate events disclosed.

For details, click here →How to read a 10-Q →

Key details

FilerPassage BIO, Inc.
Arrangement counterpartyGemma Biotherapeutics Inc.

How PASG stock reacted

Close before

$3.72

Nov 9, 2026

First close after

+1.61%

$3.78

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PASG, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PASG?

Click here

Frequently asked questions

What did PASG file with the SEC on Nov 10, 2026?

PASG filed a 10-Q (SEC filing). Passage BIO filed its Q3 2026 10-Q, reporting continued operating losses and a going concern uncertainty, with no major corporate events disclosed.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did PASG stock react to this filing?

PASG closed at $3.72 before the filing and $3.78 on Nov 10, 2026 (+1.61%).

Other PASG SEC filings

Get alerts when PASG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PASG overviewPASG analysisPASG newsLatest SEC filings